期刊
JOURNAL OF PINEAL RESEARCH
卷 45, 期 2, 页码 157-165出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1600-079X.2008.00570.x
关键词
Alzheimer's disease; amyloid-beta; melatonin; microglia; NADPH oxidase; superoxide anion
Melatonin shows significant protective effects in Alzheimer's disease (AD) models in vitro and in vivo; these effects are related to its function as an antioxidant. The source of reactive oxygen species (ROS) generation in the AD brain is primarily the amyloid-beta (A beta)- activated microglial nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. However, the effects of melatonin on the activation of NADPH oxidase remain unclear. In the present study, the cultures of microglia were incubated in the presence of fibrillar A beta(1-42), which induces the assembly and the activation of NADPH oxidase, and triggers the production of superoxide anion-derived ROS. Pretreatment of microglia with melatonin dose-dependently prevents the activation of NADPH oxidase and decreases the production of ROS. Melatonin inhibits the phosphorylation of the p47(phox) subunit of NADPH oxidase via a PI3K/Akt-dependent signalling pathway, blocks the translocation of p47(phox) and p67(phox) subunit to the membrane, down-regulates the binding of p47(phox) to gp91(phox), and impairs the assembly of NADPH oxidase. Our data offer new insights into the mechanism of inhibiting ROS generation by melatonin in A beta-activated microglia. Inhibition of ROS production indirectly might be the underlying mechanism for the neuroprotection by melatonin in the AD brain.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据